Oral Non Peptide GLP 1 Receptor Agonist Market is segmented into Type, Application, Distribution Channel, and By Region Novo Nordisk A/S, Eli Lilly and Company, Pfizer Inc., Roche Holding AG, Structure Therapeutics Inc., Amgen Inc., Viking Therapeutics Inc., AstraZeneca PLC, Boehringer Ingelheim, Merck & Co., Inc., Carmot Therapeutics, Sciwind Biosciences, Hanmi Pharmaceutical, Metsera Inc., Regor Therapeutics Group, Chugai Pharmaceutical Co., Ltd., Zealand Pharma A/S, Altimmune Inc., Innovent Biologics Inc., and Jiangsu Hengrui Pharmaceuticals
Therefore, if you are trying to split the dose, it may increase the following risks: Microdosing is associated with a higher chance of inaccurate dosing (too little or too much dose)
Arch Intern Med
was supported by a Takeda Science Foundation 2019 Medical Research Grant and Japan Science and Technology Agency PRESTO (18069571)